EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Blood Biomarker‐Based Predictive Indicator for Liver Metastasis in Alpha‐Fetoprotein‐Producing Gastric Cancer and Multi‐Omics Tumor Microenvironment Insights

Yongfeng Ding, Yiran Chen, Jing Zhang, Qingrui Wang, Songting Zhu, Junjie Jiang, Chao He, Jincheng Wang, Laizhen Tou, Jingwei Zheng, Bicheng Chen, Sizhe Hu und 15 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202503499 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Advanced Science, 2025. Verfasst von Yongfeng Ding und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Tumor Microenvironment, Liver Neoplasms, alpha-Fetoproteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alpha‐fetoprotein‐producing gastric cancer (AFPGC) is a rare but highly aggressive subtype of gastric cancer. Patients with AFPGC are at high risk of liver metastasis, and the tumor microenvironment (TME) is complex. A multicenter retrospective study is conducted from January 2011 to December 2021 and included 317 AFPGC patients. Using a multivariable logistic regression model, a nomogram for predicting liver metastasis is built. By combining AFP and the neutrophil–lymphocyte ratio (NLR), we developed a novel and easily applicable predictive indicator, termed ANLiM score, for liver metastasis in AFPGC. An integrated multi‐omics analysis, including whole‐exome sequencing and proteomic analysis, is conducted and revealed an immunosuppressive TME in AFPGC with liver metastasis. Single‐cell RNA sequencing and multiplex immunofluorescence identified the potential roles of tumor‐associated neutrophils and tertiary lymphoid structures in shaping the immune microenvironment. These findings are validated in a real‐world cohort receiving anti‐programmed cell death 1 (anti‐PD‐1) therapy, which showed concordant effectiveness. In addition, the ANLiM score is also identified as a promising biomarker for predicting immunotherapy efficacy. Overall, a blood biomarker‐based predictive indicator is developed for liver metastasis and immunotherapy response in AFPGC. The findings on immune microenvironmental alterations for AFPGC with liver metastasis provide new insights for optimizing immunotherapy strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsTumor MicroenvironmentLiver Neoplasmsalpha-FetoproteinsBiomarkers, TumorHumansMaleRetrospective StudiesFemaleMiddle AgedAgedNeutrophilsMultiomics

Stichwörter der Autor:innen

alpha‐fetoprotein‐producing gastric cancerimmunotherapyliver metastasistumor microenvironment

Substanzen

alpha-FetoproteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China.
  • Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China.
  • State Key Laboratory of Advanced Drug Delivery and Release Systems & Zhejiang Provincial Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310000, China.
  • Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, 310000, China.
  • Department of Radiology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China.
  • Department of Gastrointestinal Surgery, Lishui Central Hospital, the Fifth Hospital Affiliated to Wenzhou Medical University, Lishui, 323000, China.

ORCID-Profile: Lisong Teng

Zitieren

APA

Ding, Y., Chen, Y., Zhang, J., Wang, Q., Zhu, S., Jiang, J., He, C., Wang, J., Tou, L., Zheng, J., Chen, B., Hu, S., Yu, X., Wang, H., Lu, Y., Kong, M., Chen, Y., Wang, H., Zhang, H., …, & Teng, L. (2025). Blood Biomarker‐Based Predictive Indicator for Liver Metastasis in Alpha‐Fetoprotein‐Producing Gastric Cancer and Multi‐Omics Tumor Microenvironment Insights. Advanced Science. https://doi.org/10.1002/advs.202503499

Vancouver

Ding Y, Chen Y, Zhang J, Wang Q, Zhu S, Jiang J, et al. Blood Biomarker‐Based Predictive Indicator for Liver Metastasis in Alpha‐Fetoprotein‐Producing Gastric Cancer and Multi‐Omics Tumor Microenvironment Insights. Advanced Science. 2025. doi:10.1002/advs.202503499

BibTeX
@article{Ding2025,
  author = {Ding, Yongfeng and Chen, Yiran and Zhang, Jing and Wang, Qingrui and Zhu, Songting and Jiang, Junjie and He, Chao and Wang, Jincheng and Tou, Laizhen and Zheng, Jingwei and Chen, Bicheng and Hu, Sizhe and Yu, Xiongfei and Wang, Haohao and Lu, Yimin and Kong, Mei and Chen, Yanyan and Wang, Haiyong and Zhang, Haibin and Xu, Hongxia and Teng, Fei and Shen, Xian and Xu, Nong and Ruan, Jian and Zhou, Zhan and Lu, Jun and Teng, Lisong},
  title = {Blood Biomarker‐Based Predictive Indicator for Liver Metastasis in Alpha‐Fetoprotein‐Producing Gastric Cancer and Multi‐Omics Tumor Microenvironment Insights},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202503499}
}
Kostenlos starten →